2024-09-12 10:25 Regulatory Interim
Correction due to missing MAR-legend Significantly increased sales in the USA and much improved cash flow Significant events during the first quarter Significant events after the end of the period Webcast:When: 12 September 2024, 3 PM to 4 PM CETWhere...
2024-09-12 08:00 Regulatory Interim
Significantly increased sales in the USA and much improved cash flow Significant events during the first quarter Significant events after the end of the period Webcast:When: 12 September 2024, 3 PM to 4 PM CETWhere: registration via: Biovica Q1 Earnings...
2024-06-18 08:00 Regulatory Interim
Steadily increasing sales in the USA Significant events during the first three quarters Significant events during the fourth quarter Significant events after the end of the period Webcast:When: 18 June 2024, 3 PM to 4 PM CETWhere: registration via lyyti...
2024-03-14 08:00 Regulatory Interim
Several new commercial agreements signed and evidence that DiviTum® TKa significantly improves clinical routines in the USA. Significant events during the third quarter Significant events after the end of the period Webcast:When: 14/3 2024 kl. 15.00...
2023-11-28 08:00 Regulatory Interim
Continued sales growth and several commercial agreements signed! Significant events during the second quarter Significant events after the end of the period Webcast:When: 28/11 2023 kl. 15.00 CETWhere: register via lyyti: https://www.lyyti.fi/reg/Biovica_Q2_Earnings_call_2023__Live_Event_2257Broadcast...
2023-09-06 08:00 Regulatory Interim
Higher sales and commercial milestones achieved in the USA Significant events during the first quarter Significant events after the end of the period Webcast:When: 21 June 2023, 3 PM to 4 PM CETWhere: registration via lyyti: https://www.lyyti.in/Biovica_Q1_Earnings_call_2023__Live_Event_3956Broadcast...
2023-06-21 08:00 Regulatory Interim
Significant events during the first three quarters Significant events during the fourth quarter Significant events after the end of the period Webcast: When: 21 June 2023, 3 PM to 4 PM CET Where: registration via lyyti: https://www.lyyti.in/Q4_Earnings_Call...
2023-03-16 08:00 Regulatory Interim
2022-12-15 08:00 Regulatory Interim
Successful capital acquisition paves the way for launch in the USA Significant events during the second quarter Significant events after the end of the period Webcast: When: 15 December 2022 at 15.00 CET Where: registration via lyyti Broadcast language...
2022-08-31 08:00 Regulatory Interim
Significant events during the first quarter · Results with DiviTum®TKa at ASCO · DiviTum®TKa highlighted at ASCO in an oral presentation · Biovica’s CFO will terminate employment in December 2022 ·...

>4,500

Numbers of patients in studies

28

Publications

22

Pharma Projects

Are you a US resident?

Only US residents will be able to qualify for this program

No